2024 Oxford Nanopore — Endpoints summarized MHRA-visible disclosure about study data handling review
Data compromised
Clinical study–adjacent materials referenced in pharma press.
Technical writeup
Endpoints reported Oxford Nanopore filed UK regulatory correspondence about potential mishandling of trial-related materials tied to a security review.
Root cause
Regulatory-facing review; limited public technical detail.